AbbVie and Iambic Announce Collaboration to Accelerate AI-driven Drug Discovery
<p>Multi-year partnership applies Iambic's AI platform to speed up small molecule drug discovery in immunology, neuroscience and oncology Companies to pursue programs with both first-in-class and best-in-class potential, combining Iambic's molecular superintelligence platform with AbbVie's...</p>
Read original article ↗
Related Articles
Four Players Claim Americas Cardroom Daily Double Jackpot Shares on the Same Night
Two players qualified in Loncar and two more in Boski, producing four 10% progressive-jackpot shares totaling $12,894.30
TAMPA, Fla., Sept. 21, 2026 /PRNewswire/ -- (Nasdaq: CAE) (TSX: CAE) – CAE USA announced today that it has been awarded
AI visibility platform Searchable acquires New York's Meridian in seven-figure deal
The UK's largest answer engine optimization (AEO) startup is expanding in the United States, acquiring Meridian's produc
How Europe’s energy shock is fuelling the far right ahead of elections
Far-right parties in Europe are exploiting the fuel crisis, blaming the mainstream for soaring energy bills. With key el